The SARM1 targeting therapeutics market is project..

created a new article

Translate 2 yrs

The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040 | #sarm1 inhibitors # therapeutic agents # neurological disorders # SARM1 # Market Research # Market Insights

The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040

SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share

Comment

512